Wells Fargo & Company Utah Medical Products Inc Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Utah Medical Products Inc stock. As of the latest transaction made, Wells Fargo & Company holds 2,346 shares of UTMD stock, worth $131,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,346

Previous 1,985 18.19%

Holding current value

$131,845

Previous $112,000 31.25%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$54.95 - $63.44 $19,836 - $22,901	361 Added 18.19%	2,346 $147,000
Q2 2025 Aug 14, 2025	BUY	$51.75 - $57.36 $4,916 - $5,449	95 Added 5.03%	1,985 $112,000
Q1 2025 May 13, 2025	SELL	$56.04 - $64.17 $2,073 - $2,374	-37 Reduced 1.92%	1,890 $105,000
Q4 2024 Feb 12, 2025	BUY	$60.9 - $68.52 $23,385 - $26,311	384 Added 24.89%	1,927 $118,000
Q3 2024 Nov 13, 2024	BUY	$65.79 - $75.08 $2,039 - $2,327	31 Added 2.05%	1,543 $103,000

Q2 2024 Aug 13, 2024	BUY	$65.92 - $70.99 $19,776 - $21,297	300 Added 24.75%	1,512 $101,000
Q1 2024 May 10, 2024	BUY	$68.14 - $84.23 $9,471 - $11,707	139 Added 12.95%	1,212 $86,000
Q4 2023 Feb 09, 2024	BUY	$77.07 - $87.05 $15,568 - $17,584	202 Added 23.19%	1,073 $90,000
Q3 2023 Nov 13, 2023	SELL	$83.86 - $99.16 $61,050 - $72,188	-728 Reduced 45.53%	871 $74,000
Q2 2023 Aug 15, 2023	BUY	$87.76 - $99.95 $66,960 - $76,261	763 Added 91.27%	1,599 $149,000
Q1 2023 May 12, 2023	BUY	$87.14 - $100.3 $57,599 - $66,298	661 Added 377.71%	836 $79,000
Q4 2022 Feb 13, 2023	SELL	$82.45 - $101.88 $4,782 - $5,909	-58 Reduced 24.89%	175 $17,000
Q3 2022 Nov 14, 2022	SELL	$80.73 - $95.26 $2,744 - $3,238	-34 Reduced 12.73%	233 $20,000
Q2 2022 Aug 12, 2022	SELL	$81.49 - $90.28 $396,856 - $439,663	-4,870 Reduced 94.8%	267 $23,000
Q1 2022 May 16, 2022	SELL	$86.04 - $99.89 $533,792 - $619,717	-6,204 Reduced 54.7%	5,137 $461,000
Q4 2021 Feb 14, 2022	SELL	$88.84 - $124.71 $44,331 - $62,230	-499 Reduced 4.21%	11,341 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$84.89 - $97.16 $530,562 - $607,250	6,250 Added 111.81%	11,840 $1.1 Million
Q2 2021 Aug 16, 2021	SELL	$82.4 - $89.39 $663,814 - $720,125	-8,056 Reduced 59.04%	5,590 $476,000
Q1 2021 May 13, 2021	BUY	$83.74 - $92.99 $283,124 - $314,399	3,381 Added 32.94%	13,646 $1.18 Million
Q4 2020 Feb 09, 2021	SELL	$79.35 - $94.4 $72,525 - $86,281	-914 Reduced 8.18%	10,265 $865,000
Q3 2020 Nov 05, 2020	BUY	$78.22 - $92.62 $127,889 - $151,433	1,635 Added 17.13%	11,179 $893,000
Q2 2020 Aug 13, 2020	BUY	$78.0 - $106.28 $9,048 - $12,328	116 Added 1.23%	9,544 $845,000
Q1 2020 May 14, 2020	BUY	$77.05 - $108.52 $726,427 - $1.02 Million	9,428 New	9,428 $886,000

Others Institutions Holding UTMD

# of Institutions

116

Shares Held

2.14M

Call Options Held

Put Options Held

View Full List

About UTAH MEDICAL PRODUCTS INC

Ticker UTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 3,625,200
Market Cap $204M
Description
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...

More about UTMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Utah Medical Products Inc Transaction History